These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22558299)

  • 1. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS).
    Brocato R; Josleyn M; Ballantyne J; Vial P; Hooper JW
    PLoS One; 2012; 7(4):e35996. PubMed ID: 22558299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.
    Haese N; Brocato RL; Henderson T; Nilles ML; Kwilas SA; Josleyn MD; Hammerbeck CD; Schiltz J; Royals M; Ballantyne J; Hooper JW; Bradley DS
    PLoS Negl Trop Dis; 2015; 9(6):e0003803. PubMed ID: 26046641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccine-derived human IgG produced in transchromosomal bovines protect in lethal models of hantavirus pulmonary syndrome.
    Hooper JW; Brocato RL; Kwilas SA; Hammerbeck CD; Josleyn MD; Royals M; Ballantyne J; Wu H; Jiao JA; Matsushita H; Sullivan EJ
    Sci Transl Med; 2014 Nov; 6(264):264ra162. PubMed ID: 25429055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.
    Custer DM; Thompson E; Schmaljohn CS; Ksiazek TG; Hooper JW
    J Virol; 2003 Sep; 77(18):9894-905. PubMed ID: 12941899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus.
    Hooper JW; Ferro AM; Wahl-Jensen V
    J Virol; 2008 Feb; 82(3):1332-8. PubMed ID: 18032485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.
    Kwilas S; Kishimori JM; Josleyn M; Jerke K; Ballantyne J; Royals M; Hooper JW
    Curr Gene Ther; 2014; 14(3):200-10. PubMed ID: 24867065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus.
    Brown KS; Safronetz D; Marzi A; Ebihara H; Feldmann H
    J Virol; 2011 Dec; 85(23):12781-91. PubMed ID: 21917979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).
    Hooper JW; Josleyn M; Ballantyne J; Brocato R
    Vaccine; 2013 Sep; 31(40):4314-21. PubMed ID: 23892100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model.
    Sroga P; Sloan A; Warner BM; Tierney K; Lew J; Liu G; Chan M; Deschambault Y; Stein DR; Soule G; Banadyga L; Falzarano D; Safronetz D
    Sci Rep; 2021 Aug; 11(1):17440. PubMed ID: 34465819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.
    Brocato RL; Hammerbeck CD; Bell TM; Wells JB; Queen LA; Hooper JW
    J Virol; 2014 Jan; 88(2):811-9. PubMed ID: 24198421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virus.
    Ogg M; Jonsson CB; Camp JV; Hooper JW
    Viruses; 2013 Nov; 5(11):2704-20. PubMed ID: 24217424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters.
    Hammerbeck CD; Brocato RL; Bell TM; Schellhase CW; Mraz SR; Queen LA; Hooper JW
    J Virol; 2016 Jul; 90(14):6200-6215. PubMed ID: 27099308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates.
    Hooper JW; Custer DM; Smith J; Wahl-Jensen V
    Virology; 2006 Mar; 347(1):208-16. PubMed ID: 16378630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lethal disease model for hantavirus pulmonary syndrome.
    Hooper JW; Larsen T; Custer DM; Schmaljohn CS
    Virology; 2001 Oct; 289(1):6-14. PubMed ID: 11601912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
    Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
    J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicular Stomatitis Virus-Based Vaccines Provide Cross-Protection against Andes and Sin Nombre Viruses.
    Warner BM; Stein DR; Jangra RK; Slough MM; Sroga P; Sloan A; Frost KL; Booth S; Chandran K; Safronetz D
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31337019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term single-dose efficacy of a vesicular stomatitis virus-based Andes virus vaccine in Syrian hamsters.
    Prescott J; DeBuysscher BL; Brown KS; Feldmann H
    Viruses; 2014 Jan; 6(2):516-23. PubMed ID: 24492621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Syrian hamster model of hantavirus pulmonary syndrome.
    Safronetz D; Ebihara H; Feldmann H; Hooper JW
    Antiviral Res; 2012 Sep; 95(3):282-92. PubMed ID: 22705798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andes virus M genome segment is not sufficient to confer the virulence associated with Andes virus in Syrian hamsters.
    McElroy AK; Smith JM; Hooper JW; Schmaljohn CS
    Virology; 2004 Aug; 326(1):130-9. PubMed ID: 15262501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo activity of ribavirin against Andes virus infection.
    Safronetz D; Haddock E; Feldmann F; Ebihara H; Feldmann H
    PLoS One; 2011; 6(8):e23560. PubMed ID: 21853152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.